28 November 2022
SHARE NOW
ATW
CAR-X
Cell Therapy
Gene Editing
Gene Therapy
Patient Access & Engagement
Courtney Horvath, Global Head of Strategy, Planning and Operations, Translational Medicine at Novartis (NIBR), sat down to talk with Phacilitate’s Editor Georgi Makin to ahead of her appearance and presentation at Advanced Therapies Week 2023.
Courtney shares with us unique perspective on the the use of advanced therapies in oncology, based on her first-hand experience both professionally, at Novartis, and personally, with her son Colby’s journey as a pediatric oncology patient. She notes how advanced therapies such as CAR-T have the potential revolutionise oncological medicine – but first we must tackle the issue of patient access.
Don’t miss Courtney’s presentation ‘Advancing the Frontline’ in the session, ‘What Is The Public and Patient Perception of Cell and Gene Therapies?’, at ATW23, Wednesday 18th January, 2023.
Join us at Advanced Therapies Week >>
More like this
ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies
We caught up with Patrick M Gailliot, Sr. Director, Patient Operations at Abeona Therapeutics, to talk to him about why his work gives him so much joy, preview his session at Advanced Therapies Week in Dallas, and explain the value he gets from the event.
26 November 2024
Texas Cell and Gene Manufacturing Landscape
Ahead of Advanced Therapies Week 2025 in Dallas, we take a look at the Texas cell and gene manufacturing landscape.
19 November 2024
Full Agenda Released for Advanced Therapies Week 2025 in Dallas
Phacilitate Unveils Full Agenda for Advanced Therapies Week 2025, Bringing Together Leaders to Shape the Future of Healthcare
12 November 2024
